TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Smerud Medical Research Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
188
|
58
|
20 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
52
|
-44
|
-74 |
| EBITDA |
52
|
-44
|
-74 |
| Total assets |
175
|
170
|
127 |
| Current assets |
175
|
170
|
127 |
| Current liabilities |
112
|
159
|
115 |
| Equity capital |
63
|
11
|
12 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
36.0%
|
6.5%
|
9.4% |
| Turnover per employee |
188
|
58
|
20 |
| Profit as a percentage of turnover |
27.7%
|
-75.9%
|
-370.0% |
| Return on assets (ROA) |
29.7%
|
-25.9%
|
-58.3% |
| Current ratio |
156.2%
|
106.9%
|
110.4% |
| Return on equity (ROE) |
82.5%
|
-400%
|
-616.7% |
| Change turnover |
130
|
40
|
-125 |
| Change turnover % |
223%
|
214%
|
-86% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.